Pr Laurent Greillier

Specialty

Oncologist, lung expert

Title

Head of department

Hospital

AP-HM Hôpital Nord (Marseille)

Latest articles

• Adjuvant Durvalumab in Completely Resected Early-Stage Non-Small Cell Lung Cancer. (Jan 13, 2026)
• Rebiopsy Feasibility and Clinical Impact on Metastatic Non-Small-Cell Lung Cancer With EGFR/ALK/ROS Oncogenic Driver Progression After Optimal Targeted Therapy: A Multicenter Real-World Analysis. (Dec 1, 2025)
• Real-world efficacy and safety of amivantamab in EGFR exon-20-mutant non-small cell lung cancer in a French early-access program: Amexon 20 GFPC study. (Nov 1, 2025)
• Place in therapy of key treatments for platinum-sensitive, relapsed, extensive-stage small cell lung cancer with a focus on lurbinectedin: a narrative review with case studies. (Oct 29, 2025)
• Durvalumab in Patients With Treatment-Naive Stage IV NSCLC With an ECOG Performance Status of 2 to 3 and High PD-L1 Tumor Expression (IFCT-1802 SAVIMMUNE): A Multicenter Phase 2 Trial. (Sep 18, 2025)